Home / In a nutshell

  • In this study, we are testing a new online doctor-patient tool for adults with multiple sclerosis (MS) and their MS healthcare providers (e.g., doctors, nurses, physician assistants).
  • You may be given access to the new online doctor-patient tool that is being tested for people with MS.
  • The doctor-patient tool will ask you questions about how you manage your MS, how MS affects your life, and what matters to you.
  • It gives you personalized feedback. It creates a short summary to help you talk with your medical team.
  • We will suggest you share that summary with your healthcare provider.
  • Participants are limited to people with a relapsing form of MS who have a scheduled appointment within the next 12 weeks with their healthcare provider.
  • This includes Relapsing Remitting MS (RRMS or RMS), secondary progressive MS (SPMS) with relapses (also known as “active SPMS”), or Clinically Isolated Syndrome (CIS).
  • You will be asked to complete six online surveys over the next 12 to 15 months regarding your MS and use of disease modifying therapies (DMT), if any.
  • The initial survey will take about 30 minutes, the remaining surveys will take between 5 and 15 minutes.
  • Taking part in this research is voluntary. Whether you take part is up to you. If you don’t take part, it won’t be held against you.
  • You can take part now and later drop out, and it won’t be held against you.
  • This study is sponsored by Shared Decision Making Resources under a Scientific Research with Agreement EMD Serono, a business of Merck KGaA, Darmstadt, Germany and in partnership with the Multiple Sclerosis Association of America (MSAA).